The Pharmaceutical Suppositories by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Pharmaceutical Suppositories Market:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-suppositories-global-market-report
According to The Business Research Company’s Pharmaceutical Suppositories, The pharmaceutical suppositories market size has grown strongly in recent years. It will grow from $1.6 billion in 2023 to $1.7 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increased healthcare expenditure, new regulatory approvals for marketing suppositories, government initiatives, the rise in prevalence of constipation and the increasing prevalence of diseases..
The pharmaceutical suppositories market size is expected to see strong growth in the next few years. It will grow to $2.19 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increase in prevalence of kidney damage or failure and an increase in prevalence of hemorrhoids. Major trends in the forecast period include strategic partnerships, technological advancements, product innovation and focus on patient convenience and adherence. .
The increasing prevalence of diseases is expected to propel the pharmaceutical suppositories market going forward. The prevalence of diseases is rising mainly due to factors such as geology and climate, and insects that transmit the agent. Pharmaceutical suppositories help treat the increasing number of patients with various diseases due to the increasing prevalence of diseases. A pharmaceutical suppository is an additional drug delivery method that inserts a small, cylindrical, or conical device into the body, usually into the bottom which dissolves or melts releasing the drug to cure the disease. For instance, according to the report by the Australian Institute of health and welfare, over 4,700 hospitalizations were reported to have COVID-19 infection in 2020–2021. Viral pneumonia (24% of cases), 'COVID-19 infection' (19%), and symptoms including cough (9.9%), fever (6.6%), and breathing problems (4.8%) were the most frequent primary diagnoses recorded alongside other infectious diseases. Therefore, the increasing prevalence of diseases is driving the growth of the pharmaceutical suppositories market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8804&type=smp
The pharmaceutical suppositories market covered in this report is segmented –
1) By Type: Rectal Suppositories, Vaginal Suppositories, Urethral Suppositories, Other Types
2) By Base: Fatty Base, Water Miscible Bases, Emulsifying Bases
3) By End-User: Hospitals And Clinics, Nursing Homes, Home Care, Other End Users
Technological advancements are a key trend gaining popularity in the pharmaceutical suppositories market. Major companies operating in the pharmaceutical suppositories market are using advanced technologies to sustain their position in the pharmaceutical suppositories market. For instance, in March 2021, CB21 Pharma, a subsidiary of CBDepot, a US-based manufacturer and B2B provider of high-end cannabis products, launched CANNEFF VAG SUP vaginal suppositories and CANNEFF SUP rectal suppositories. CANNEFF VAG SUP is used for further therapy for the healing of atrophic and dystrophic vaginal mucous membrane disorders whereas CANNEFF SUP is utilized as a supplement to proctological procedures, proctitis, cryptitis, anal fissures, and perianal fistula to aid in the anorectal canal disorders' healing processes.
The pharmaceutical suppositories market report table of contents includes:
1. Executive Summary
2. Pharmaceutical Suppositories Market Characteristics
3. Pharmaceutical Suppositories Market Trends And Strategies
4. Pharmaceutical Suppositories Market analysis
5.Pharmaceutical Suppositories Market Size And Growth
6. Pharmaceutical Suppositories Segmentation
7. Pharmaceutical Suppositories Regional And Country Analysis
.
.
.
27.Pharmaceutical Suppositories Competitive Landscape And Company Profiles
28.Pharmaceutical Suppositories Key Mergers And Acquisitions
29. Pharmaceutical SuppositoriesFuture Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Bayer AG
- Pfizer Inc.
- Novartis International Ag
- Sanofi S.A.
- Intas Pharmaceuticals Ltd.
- Unither Pharmaceuticals
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Process Analytical Technology (PAT) Market was valued at USD 2.36 Billion in 2019 and is projected to reach USD 4.96 Billion by 2027, growing at a CAGR of 9.95% from 2020 to 2027.Global Process Analytical Technology (PAT) Market OverviewInnovations in process analytical chemistry (process analysers) and its ability to capture & interpret vast amounts of data are the leading elements that have boosted the adoption of process analytical technology system in the pharmaceutical industry.
